Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 67
Filtrar
1.
J Perinatol ; 29(4): 284-9, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19148110

RESUMO

OBJECTIVE: An endogenous digitalis-like factor (EDLF) has been implicated in the pathophysiology of preeclampsia (PE). This hypothesis is supported by two cases of preeclampsia in which administration of digoxin immune Fab (DIF) reduced mean arterial pressure (MAP). STUDY DESIGN: To study this observation further, we performed a double-blind, placebo-controlled, randomized clinical trial to examine the effects on MAP of intravenous DIF given after delivery in 26 subjects with severe preeclampsia. Treating obstetricians were blinded to subject assignment and were allowed to use standard antihypertensive drugs during the trial. RESULTS: The primary outcome, a significant difference in blood pressure between the two groups over the 24-h period of observation after the intervention, was not supported. However, mean MAP was significantly lower in the DIF-treated subjects for the first 4 h after therapy as compared with controls (P=0.05). Six subjects (46.2%) in the placebo arm were given conventional antihypertensive medications by their obstetrician for blood pressure >160 mm Hg systolic or >110 mm Hg diastolic, compared with zero subjects in the treatment arm (P=0.01). A trend towards increased creatinine clearance was observed in DIF-treated subjects (137.6+/-42.6 versus 104.1+/-43.4, P=0.07). CONCLUSION: These results support the hypothesis that EDLF contributes to the elevated blood pressure in preeclampsia and suggests a possible role for DIF as a treatment for this condition.


Assuntos
Anti-Hipertensivos/administração & dosagem , Pressão Sanguínea/efeitos dos fármacos , Fragmentos Fab das Imunoglobulinas/administração & dosagem , Pré-Eclâmpsia/tratamento farmacológico , Adolescente , Adulto , Pressão Sanguínea/fisiologia , Creatinina/sangue , Método Duplo-Cego , Feminino , Humanos , Recém-Nascido , Infusões Intravenosas , Terceira Fase do Trabalho de Parto , Pré-Eclâmpsia/fisiopatologia , Gravidez , Adulto Jovem
2.
J Perinatol ; 29(4): 280-3, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19158804

RESUMO

OBJECTIVE: Elevated blood levels of endogenous digitalis-like factors (EDLF) may decrease erythrocyte sodium pump activity in preeclampsia. As the highest EDLF levels might be expected in severe preeclampsia, we investigated sodium pump activity in that group of patients. STUDY DESIGN: Erythrocyte sodium pump activity was determined by (86)Rubidium uptake (in nM per hour per 10(6) cells) in women with severe preeclampsia and those with normal pregnancies, matched for gestational age, and in healthy nonpregnant women (n=12 in each group). Differences between groups were analyzed by a two-sided Student t-test. RESULT: Sodium pump activity was significantly increased in normotensive pregnancies as compared with normotensive non-pregnant women (81.4+/-8.4 vs 61.1+/-7.4, mean+/-s.d., p<0.05), and was decreased 43% in severe preeclamptic pregnancies as compared with normotensive pregnancies (46.4+/-14.1 vs 81.4+/-8.4, p<0.05). CONCLUSION: Severe preeclampsia is associated with significantly lower erythrocyte sodium pump activity than normotensive pregnancy. These data suggest that plasma levels of a biologically active EDLF are elevated in patients with severe preeclampsia.


Assuntos
Eritrócitos/enzimologia , Pré-Eclâmpsia/enzimologia , ATPase Trocadora de Sódio-Potássio/sangue , Adolescente , Adulto , Cardenolídeos/sangue , Feminino , Humanos , Recém-Nascido , Gravidez , Valores de Referência , Saponinas/sangue , Adulto Jovem
3.
Am J Obstet Gynecol ; 185(4): 822-7, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11641659

RESUMO

OBJECTIVE: The purpose of this study was to determine the effects of pregnancy and of maximal exercise on left ventricular diastolic filling response. STUDY DESIGN: Transmitral pulsed Doppler echocardiography was obtained in 10 healthy women during each trimester of pregnancy and at 12 weeks after delivery. Doppler studies were performed at rest and at each exercise workload. The P-R interval, the early and atrial peak flow velocities, the mitral early deceleration time, and the isovolumetric relaxation time were analyzed. Data are expressed as the mean and standard deviation of the mean. Values obtained during the last trimester of pregnancy were used as the pregnant value; values at the 12 weeks after delivery were used as the nonpregnant value. Paired t -test, analysis of variance, and mixed models were used to determine significance with a probability value of <.05. RESULTS: Pregnancy significantly increased the early and atrial peak flow velocities. Pregnancy decreased the P-R interval, the early deceleration time, and the isovolumetric relaxation time. Exercise significantly decreased these diastolic functions; but pregnancy, in any of the 3 trimesters, did not significantly affect this response. CONCLUSION: Pregnancy increased left ventricular diastolic camber stiffness at rest and shifted left ventricular diastolic filling during exercise from predominantly early to atrial filling. This finding suggests that there is an increase in left ventricular chamber stiffness during maximal upright bicycle exercise in pregnancy.


Assuntos
Teste de Esforço , Exercício Físico/fisiologia , Gravidez/fisiologia , Função Ventricular Esquerda/fisiologia , Adulto , Análise de Variância , Débito Cardíaco , Diástole/fisiologia , Ecocardiografia Doppler , Feminino , Testes de Função Cardíaca , Humanos , Período Pós-Parto , Terceiro Trimestre da Gravidez , Probabilidade , Valores de Referência , Sensibilidade e Especificidade
4.
Am J Obstet Gynecol ; 182(5): 1173-83, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10819855

RESUMO

OBJECTIVES: This study was designed to evaluate the efficacy and safety of the oxytocin receptor antagonist atosiban in the treatment of preterm labor. STUDY DESIGN: A multicenter, double-blind, placebo-controlled trial with tocolytic rescue was designed. Five hundred thirty-one patients were randomized to receive, and 501 received, either intravenous atosiban (n = 246) or placebo (n = 255), followed by subcutaneous maintenance with the assigned agent. Standard tocolytics as rescue tocolysis were permitted after 1 hour of either placebo or atosiban if preterm labor continued. The primary end point was the time from the start of study drug to delivery or therapeutic failure. Secondary end points were the proportion of patients who remained undelivered and did not receive an alternate tocolytic at 24 hours, 48 hours, and 7 days. RESULTS: No significant difference was found in the time from start of treatment to delivery or therapeutic failure between atosiban and placebo (median, 25.6 days vs 21.0 days, respectively; P =.6). The percentages of patients remaining undelivered and not requiring an alternate tocolytic at 24 hours, 48 hours, and 7 days were significantly higher in the atosiban group than in the control group (all P < or =.008). A significant treatment-by-gestational age interaction existed for the 48-hour and 7-day end points. Atosiban was consistently superior to placebo at a gestational age of > or =28 weeks. Fourteen atosiban-treated patients and 5 placebo-treated patients were randomized at <24 weeks; the incidence of fetal-infant deaths was higher for the atosiban group at <24 weeks. Maternal-fetal adverse events were similar except for injection-site reactions, which occurred more often with atosiban. CONCLUSIONS: In this trial the treatment of patients in preterm labor with atosiban resulted in prolongation of pregnancy for up to 7 days for those at a gestational age > or =28 weeks, and this occurred with a low rate of maternal-fetal adverse effects. In addition, at a gestational age > or =28 weeks, the infant morbidity and mortality of atosiban-initiated standard care were similar to those with placebo-initiated standard care. Given that all patients in this study were eligible for tocolysis and that, in practice, nearly all patients who are eligible for a tocolytic receive one, the benefit of using atosiban is the placebo-like maternal-fetal side effect profile. These observations support the use of this oxytocin receptor antagonist in the treatment of patients in preterm labor with intact membranes. Efficacy and infant outcome data at <28 weeks are inconclusive.


Assuntos
Trabalho de Parto Prematuro/tratamento farmacológico , Tocólise , Tocolíticos/uso terapêutico , Vasotocina/análogos & derivados , Método Duplo-Cego , Feminino , Morte Fetal , Sofrimento Fetal , Idade Gestacional , Humanos , Placebos , Gravidez , Fatores de Tempo , Tocolíticos/efeitos adversos , Resultado do Tratamento , Vasotocina/efeitos adversos , Vasotocina/uso terapêutico
5.
JAMA ; 283(9): 1183-8, 2000 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-10703781

RESUMO

OBJECTIVE: Peripartum cardiomyopathy (PPCM) is a rare life-threatening cardiomyopathy of unknown cause that occurs in the peripartum period in previously healthy women. In April 1997, the National Heart, Lung, and Blood Institute (NHLBI) and the Office of Rare Diseases of the National Institutes of Health (NIH) convened a Workshop on Peripartum Cardiomyopathy to foster a systematic review of information and to develop recommendations for research and education. PARTICIPANTS: Fourteen workshop participants were selected by NHLBI staff and represented cardiovascular medicine, obstetrics, immunology, and pathology. A representative subgroup of 8 participants and NHLBI staff formed the writing group for this article and updated the literature on which the conclusions were based. The workshop was an open meeting, consistent with NIH policy. EVIDENCE: Data presented at the workshop were augmented by a MEDLINE search for English-language articles published from 1966 to July 1999, using the terms peripartum cardiomyopathy, cardiomyopathy, and pregnancy. Articles on the epidemiology, pathogenesis, pathophysiology, diagnosis, treatment, and prognosis of PPCM were included. RECOMMENDATION PROCESS: After discussion of data presented, workshop participants agreed on a standardized definition of PPCM, a general clinical approach, and the need for a registry to provide an infrastructure for future research. CONCLUSIONS: Peripartum cardiomyopathy is a rare lethal disease about which little is known. Diagnosis is confined to a narrow period and requires echocardiographic evidence of left ventricular systolic dysfunction. Symptomatic patients should receive standard therapy for heart failure, managed by a multidisciplinary team. If subsequent pregnancies occur, they should be managed in collaboration with a high-risk perinatal center. Systematic data collection is required to answer important questions about incidence, treatment, and prognosis.


Assuntos
Cardiomiopatias , Complicações Cardiovasculares na Gravidez , Cardiomiopatias/diagnóstico , Cardiomiopatias/epidemiologia , Cardiomiopatias/etiologia , Cardiomiopatias/terapia , Fármacos Cardiovasculares , Congressos como Assunto , Ecocardiografia , Feminino , Humanos , Incidência , National Institutes of Health (U.S.) , Guias de Prática Clínica como Assunto , Gravidez , Complicações Cardiovasculares na Gravidez/diagnóstico , Complicações Cardiovasculares na Gravidez/epidemiologia , Complicações Cardiovasculares na Gravidez/etiologia , Complicações Cardiovasculares na Gravidez/terapia , Terceiro Trimestre da Gravidez , Gravidez de Alto Risco , Prognóstico , Transtornos Puerperais , Fatores de Risco , Estados Unidos , Disfunção Ventricular Esquerda
6.
Am J Obstet Gynecol ; 181(2): 315-9, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10454675

RESUMO

OBJECTIVE: The aim of this survey was to assess the evaluation, management, and future recommendations of patients with the diagnosis of peripartum cardiomyopathy and to evaluate the interest in the creation of a prospective database regarding this rare disorder. STUDY DESIGN: A total of 116 surveys were sent to major teaching institutions in the United States (including Puerto Rico), Canada, Crete, and South Korea after a national conference held at the National Institutes of Health regarding peripartum cardiomyopathy. This was an open-ended survey containing 17 specific questions regarding this disorder and its management. RESULTS: A total of 78 (67%) maternal-fetal specialists responded to the survey. Diuretics and digoxin were used as first-line treatment for this disorder. Only 6% used angiotensin-converting enzyme inhibitors during pregnancy. Fifty-eight percent of the perinatologists (58%) recommended either intrauterine contraceptive devices or foam and condoms, whereas oral contraceptives (progesterone-only pill or estrogen-progesterone mix) were recommended in 23% and 41%, respectively. Sixty-six percent (66%) of the respondents would recommend future pregnancy if ventricular function returned to normal. CONCLUSIONS: Fundamental clinical and basic research is lacking regarding this rare but potentially devastating disorder. Major teaching institutions do not have significant numbers of patients with this disorder to provide concrete recommendations, and starting a database will be useful in the gathering of important epidemiologic information. A secondary aim of such a registry would be to establish a repository for tissue and blood samples to answer basic mechanistic questions about this disorder.


Assuntos
Cardiomiopatias , Complicações Cardiovasculares na Gravidez , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Cardiomiopatias/epidemiologia , Cardiomiopatias/terapia , Digoxina/uso terapêutico , Diuréticos/uso terapêutico , Feminino , Inquéritos Epidemiológicos , Humanos , National Institutes of Health (U.S.) , Perinatologia , Gravidez , Complicações Cardiovasculares na Gravidez/epidemiologia , Complicações Cardiovasculares na Gravidez/terapia , Sistema de Registros , Fatores de Risco , Inquéritos e Questionários , Estados Unidos
7.
Am J Obstet Gynecol ; 180(4): 849-58, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10203652

RESUMO

OBJECTIVE: Our goal was to determine the effects of advancing age on the Doppler diastolic filling indexes from early gestation to 1 year of life. STUDY DESIGN: Seventy-nine fetuses were studied. Initial Doppler studies were started at about the 16th week of gestation and repeated every 4-6 weeks until term, on postnatal day 1 and 2, and at ages 6 weeks, 6 months, and 12 months. A minimum of 5 returning Doppler waveforms were traced and analyzed for (1) peak early flow velocity, (2) late peak atrial flow velocity, (3) total area area under the curve, and (4) the acceleration and deceleration phases. The stiffness of the ventricles was estimated. Slopes of the curves for each of the parameters were analyzed for differences across time periods and between right and left ventricles. RESULTS: (1) Heart rate significantly decreased with advancing age. (2) Left ventricular and right ventricular peak early flow velocity and late peak atrial flow velocity significantly increased during fetal life but not during the 1st year. (3) Atrial predominance was found during fetal life but not during the first year. (4) The deceleration phase of filling significantly increased during the fetal period. (5) Ventricular stiffness progressively decreased during the fetal period. (6) Increased ventricular filling shifted from a right-sided dominance in utero to a left-sided dominance after birth. CONCLUSIONS: (1) Fetuses have stiffer fetal ventricles than neonates. (2) The diastolic filling patterns in normally grown fetuses mimic those of the diseased adult heart. We speculate that this maturation process may be affected in fetuses born prematurely or small for gestational age.


Assuntos
Coração Fetal/fisiologia , Feto/fisiologia , Função Ventricular Esquerda/fisiologia , Função Ventricular Direita/fisiologia , Ecocardiografia Doppler , Feminino , Idade Gestacional , Frequência Cardíaca , Frequência Cardíaca Fetal , Humanos , Lactente , Recém-Nascido , Estudos Longitudinais , Valva Mitral/embriologia , Valva Mitral/fisiologia , Gravidez , Resultado da Gravidez , Fatores de Tempo , Valva Tricúspide/embriologia , Valva Tricúspide/fisiologia , Ultrassonografia Pré-Natal
8.
J Soc Gynecol Investig ; 5(1): 38-43, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9501297

RESUMO

OBJECTIVE: To determine if women who developed preeclampsia had measurable differences in the vascular response postrelease of a 1-minute blood flow occlusion. METHODS: A total of 33 nulliparous patients were enrolled in this study during the second half of the pregnancy. All had baseline Doppler flow velocities while resting in the left lateral decubitus. Subsequently, a blood pressure cuff was inflated for 60 seconds in the forearm so as to occlude blood flow. Doppler waveforms were analyzed immediately after the release of the blood pressure cuff and on a single beat occurring at 15 second intervals for a total of five readings. After a rest period, patients were asked to squeeze a handheld manometer at maximum strength as long as possible. Doppler waveforms were analyzed as above. The Doppler waveforms of all enrolled patients who subsequently developed preeclampsia any time after the study were compared to those who remained normotensive. RESULTS: 1) The "hyperemic response" that occurred immediately after release of the blood pressure occlusion of the forearm was significantly different between patients who subsequently developed preeclampsia compared with those who remained normotensive, 2) the hyperemic response that occurred after the isometric handgrip exercise was not significantly different between the two groups, and 3) sensitivity, specificity, and negative predictive values were high, but positive predictive values were low. CONCLUSION: There was a significant difference in the hyperemic response of the brachial artery to a short period of ischemia of the forearm (blood pressure occlusion) between normotensive patients and a group of patients who subsequently developed preeclampsia.


Assuntos
Pressão Sanguínea/fisiologia , Artéria Braquial/fisiologia , Hiperemia/fisiopatologia , Pré-Eclâmpsia/fisiopatologia , Complicações Cardiovasculares na Gravidez/fisiopatologia , Adulto , Velocidade do Fluxo Sanguíneo/fisiologia , Determinação da Pressão Arterial/métodos , Artéria Braquial/diagnóstico por imagem , Estudos de Coortes , Feminino , Humanos , Gravidez , Curva ROC , Valores de Referência , Sensibilidade e Especificidade , Fatores de Tempo , Ultrassonografia Doppler de Pulso
9.
Obstet Gynecol ; 91(2): 165-8, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9469269

RESUMO

OBJECTIVE: To determine side effect profiles and cure rates of azithromycin compared with erythromycin in the treatment of chlamydial cervicitis complicating pregnancy. METHODS: Pregnant patients with positive DNA antigen assays for Chlamydia trachomatis were randomized to either azithromycin, 1 g oral slurry in a single dose, or erythromycin, 500 mg every 6 hours for 7 days. Repeat assays were planned for 3 weeks after therapy. Side effects, compliance, and treatment efficacy were assessed. RESULTS: One hundred six women were enrolled, and eighty-five women completed the protocol. Significantly fewer gastrointestinal side effects were noted in the azithromycin group than in the erythromycin group (11.9% versus 58.1%, P < or = .01). Enhanced compliance was noted with azithromycin, because it was given in a single observed dose. Similar treatment efficacy was noted between azithromycin and erythromycin (88.1% versus 93.0%, P > .05). CONCLUSION: Compared with erythromycin, azithromycin is associated with significantly fewer gastrointestinal side effects in pregnancy. This association, along with the ease of administration and similar efficacy, suggests that azithromycin should be considered for the initial treatment of chlamydial cervicitis in pregnancy.


Assuntos
Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Infecções por Chlamydia/tratamento farmacológico , Chlamydia trachomatis , Eritromicina/uso terapêutico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Cervicite Uterina/tratamento farmacológico , Adulto , Antibacterianos/efeitos adversos , Azitromicina/efeitos adversos , Eritromicina/efeitos adversos , Feminino , Humanos , Gravidez
10.
Ultrasound Obstet Gynecol ; 9(3): 200-3, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9165685

RESUMO

We report the earliest in utero presentation of a 'giant' glioependymal cyst detected on routine prenatal ultrasound at 22 weeks estimated gestational age. The clinicopathologic features of these rare lesions are reviewed as well as previous reports of glioependymal cysts detected in utero. The effects of large intracranial cysts on neurodevelopment are discussed as well as the differential diagnosis of infantile intracranial cysts and therapeutic alternatives.


Assuntos
Encefalopatias/diagnóstico por imagem , Cistos/diagnóstico por imagem , Doenças Fetais/diagnóstico por imagem , Holoprosencefalia/diagnóstico por imagem , Ultrassonografia Pré-Natal , Adulto , Encefalopatias/patologia , Cistos/patologia , Diagnóstico Diferencial , Feminino , Doenças Fetais/patologia , Humanos , Gravidez
11.
Int J Gynaecol Obstet ; 55(2): 105-9, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8960989

RESUMO

OBJECTIVE: To assess prospectively the utility of a modification of the Mueller-Hillis maneuver in predicting abnormalities of the second stage of labor. METHODS: The Mueller-Hillis maneuver was modified by limiting its use to the second stage of labor during a contraction. The maneuver was performed by one examiner; descent of 1 cm or more was deemed a positive maneuver. Descent less than 1 cm was deemed a negative maneuver. Labor outcomes were analyzed according to the results of this maneuver. RESULTS: Seventy patients were enrolled in this study. Fifty-one (72.9%) had > or = 1 cm descent maneuver and 19 (27.1%) had < or = 1 cm descent. A descent > or = 1 cm was significantly predictive of vaginal delivery (100%) and a descent < or = 1 cm was significantly associated with an increased cesarean section rate (P = 0.001), prolonged second stage of labor (P = 0.001), abnormal position (P = 0.01) and higher station (P = 0.001). CONCLUSIONS: A positive modified Mueller-Hillis maneuver in second stage labor had a high predictive value for vaginal delivery, whereas a negative maneuver was significantly associated with high operative delivery rate, prolonged second stage labor and abnormal position. These results indicate that this modification of the Mueller-Hillis maneuver needs to be considered for its utility in second stage labor.


Assuntos
Parto Obstétrico/métodos , Segunda Fase do Trabalho de Parto , Adulto , Cesárea , Feminino , Humanos , Obstetrícia/métodos , Valor Preditivo dos Testes , Gravidez , Estudos Prospectivos , Contração Uterina
12.
Am J Obstet Gynecol ; 175(5): 1360-4, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8942515

RESUMO

OBJECTIVE: Our purpose was to examine the nature and the frequency of electrocardiographic changes at rest and after bicycle exercise in early and late gestation compared with a group of nonpregnant subjects. STUDY DESIGN: Thirty-nine pregnant subjects had electrically braked bicycle exercise early and late in gestation. Eight nonpregnant subjects served as controls. Twelve-lead electrocardiograms were obtained during rest, exercise, and recovery. All electrocardiograms were analyzed by a cardiologist blinded to subject group and stage of the pregnancy. Data were analyzed by analysis of variance for repeated measures, and contingency tables were used to compare findings at rest and during exercise between the time periods. A p value < 0.05 was considered significant. RESULTS: T-wave inversion in V2 was more frequent in the pregnant than the nonpregnant subjects (p < 0.01). Subjects "late" in pregnancy had significantly fewer Q waves in II, III, and aVF than the nonpregnant group did. With exercise the time to onset of maximum ST depression was significantly shorter during pregnancy. CONCLUSION: Although minor electrocardiographic charges were found at rest and during exercise between the two groups, these should be considered normal unless associated with significant symptoms.


Assuntos
Eletrocardiografia , Exercício Físico , Gravidez/fisiologia , Adulto , Feminino , Humanos
13.
Am J Obstet Gynecol ; 175(4 Pt 1): 922-8, 1996 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8885749

RESUMO

OBJECTIVE: Our purpose was to evaluate cardiac variables, including right and left end-diastolic and end-systolic dimensions by use of M-mode echocardiography during fetal, neonatal (transitional), and infancy periods to understand hemodynamic adaptation during these periods. STUDY DESIGN: Fifty-three fetuses were enrolled in this study. Echocardiography evaluations were started as early as the sixteenth week of gestation and were repeated every 4 to 6 weeks until term, on postnatal days 1 and 2, and at 6 weeks, 6 months, and 12 months of age. End-diastolic and end-systolic measurements were made according to published standards. Mean and SEM for each of the end-diastolic and end-systolic measurements were calculated for each of 11 study periods. Data were analyzed by one-way analysis of variance, corrected for repeated measures, and in the case of right and left ventricular differences paired t tests were used for significance. RESULTS: Left ventricular end-diastolic and end-systolic correlated positively with advancing age (R2 = 0.93, p < 0.0001), right ventricular end-diastolic also correlated with advancing age (R2 = = 0.361, p < 0.05), and right ventricular end-diastolic was significantly larger than left ventricular end-diastolic in utero (p < 0.01), whereas the opposite was true after birth (p < 0.0001). Heart rate significantly decreased with advancing age (p < 0.001), whereas ejection fraction for either the right or the left ventricle did not change significantly with advancing age. CONCLUSION: This suggests that under basal conditions the ventricles can meet the increased demands in cardiac output by increasing ventricular dimensions without having to increase contractility reserve.


Assuntos
Desenvolvimento Infantil , Ecocardiografia , Desenvolvimento Embrionário e Fetal , Ultrassonografia Pré-Natal , Diástole , Feminino , Seguimentos , Frequência Cardíaca , Septos Cardíacos/diagnóstico por imagem , Septos Cardíacos/embriologia , Septos Cardíacos/fisiologia , Ventrículos do Coração , Humanos , Lactente , Recém-Nascido , Estudos Longitudinais , Gravidez , Resultado da Gravidez , Volume Sistólico , Sístole
14.
Obstet Gynecol Surv ; 51(9): 549-58, 1996 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8873155

RESUMO

Gaucher's disease is an autosomal recessive lysosomal storage disease, resulting from a deficiency of the enzyme glucocerebrosidase, important for the physiologic recycling of cell membrane lipids. The clinical symptoms and disease presentations of Gaucher's disease are heterogeneous, including hepatosplenomegaly, bone "crisis" and fracture, anemia, thrombocytopenia and in some forms, rapid neurological decompensation. Similarly, the genetic variability of Gaucher's disease is diverse, and in some aspects affects phenotypic expression. Type 1 Gaucher's disease, however, usually present with less severe symptoms, at more advanced age, and is particularly amenable to enzyme replacement therapy with alglucerase. In type 1 patients with Gaucher's disease reproductive age is commonly reached and childbearing frequently desired with need for appropriate prenatal diagnosis, counseling and careful obstetrical surveillance. Although pregnancy concurrent with Gaucher's disease has been reported in the medical literature, only one small series of alglucerase treated Gaucher's disease during pregnancy exists. Without treatment, pregnancy concurrent with Gaucher's disease has several risks including an increased severity of anemia and thrombocytopenia that can potentiate postpartum bleeding, significant increases in organomegaly and possibly an increased spontaneous abortion rate. It is yet to be shown whether alglucerase reduces the risk of these complications during pregnancy and whether its use has any adverse effect on fetal development.


Assuntos
Doença de Gaucher , Complicações na Gravidez , Adulto , Feminino , Doença de Gaucher/classificação , Doença de Gaucher/diagnóstico , Doença de Gaucher/epidemiologia , Doença de Gaucher/genética , Doença de Gaucher/fisiopatologia , Doença de Gaucher/terapia , Glucosilceramidase/uso terapêutico , Humanos , Gravidez , Complicações na Gravidez/classificação , Complicações na Gravidez/diagnóstico , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/fisiopatologia , Complicações na Gravidez/terapia , Resultado da Gravidez , Proteínas Recombinantes/uso terapêutico
15.
Semin Perinatol ; 20(4): 250-62, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8888451

RESUMO

With the two-dimensional Doppler echocardiogram and M-mode echocardiogram, one can study maternal and fetal cardiovascular physiology during rest and exercise. Using such noninvasive techniques, studies indicate that left ventricular function is maintained even during vigorous bicycle exercise in healthy pregnant subjects during the second half of pregnancy. In early pregnancy, the left ventricle adapts to strenuous bicycle exercise by increasing its contractile reserve, enhancing ventricular emptying, whereas in late pregnancy, the left ventricle increases its preload reserve without significantly increasing its contractile reserve. Thus, women are "cardiovascularly" disadvantaged early in pregnancy. Using Doppler signals, early (E-passive) flow and late peak (A-active) flow reflect left ventricular diastolic filling properties. Using such techniques, we found that diastolic filling patterns are significantly influenced by pregnancy and that each trimester influences these diastolic filling patterns during upright bicycle exercise. Doppler studies of uteroplacental circulation during or after exercise have yielded conflicting results. Some have described an increase in "the vascular resistance" of this pelvic bed during strenuous exercise, whereas others have not. It seems safe to conclude that more studies are needed to elucidate this problem. Exercise does not seem to influence the resistivity index of the umbilical artery in either singleton or twins, and may even cause it to decrease. Ventricular diastolic filling properties of the fetal heart do not seem to be influenced by maternal bicycle exercise. Further studies are needed to determine if less active pregnant subjects, women with chronic hypertensive disorders, women with sickle cell anemia, or women with insulin-dependent diabetes adapt to exercise as well as their "normal" counterparts.


Assuntos
Fenômenos Fisiológicos Cardiovasculares , Sistema Cardiovascular/embriologia , Exercício Físico/fisiologia , Feto/fisiologia , Gravidez/fisiologia , Ecocardiografia Doppler , Feminino , Frequência Cardíaca Fetal , Humanos , Complicações na Gravidez
16.
Obstet Gynecol ; 88(2): 216-20, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8692505

RESUMO

OBJECTIVE: To evaluate the efficacy of intrapartum prophylactic administration of ampicillin-sulbactam in reducing intraamniotic infection and postpartum endometritis in patients with meconium-stained amniotic fluid (AF). METHODS: Patients with intrapartum meconium-stained AF were randomized to receive either ampicillin-sulbactam or normal saline (placebo) intravenously at the time of diagnosis of meconium and every 6 hours until delivery. The outcomes of the two groups were compared with respect to intra-amniotic infection and postpartum endometritis. RESULTS: During the study period, 332 patients with meconium-stained AF were approached for participation, and 120 patients met inclusion criteria and were enrolled. Patient demographics, labor, and delivery characteristics were similar. Ampicillin-sulbactam reduced the incidence of intra-amniotic infection from 23.3 to 6.7%, (P = .02; relative risk [RR] 0.48, 95% confidence interval [CI] 0.22-0.98). The incidence of postpartum endometritis was also reduced, but the difference was statistically nonsignificant (8.3 versus 16.7%, P = .16; RR 0.64, 95% CI 0.30-1.33). CONCLUSION: Prophylactic intravenous ampicillin-sulbactam significantly reduces intra-amniotic infection in patients with meconium-stained AF.


Assuntos
Líquido Amniótico , Ampicilina/uso terapêutico , Antibacterianos/uso terapêutico , Infecções Bacterianas/prevenção & controle , Endometrite/prevenção & controle , Doenças Fetais/prevenção & controle , Mecônio , Complicações do Trabalho de Parto/prevenção & controle , Penicilinas/uso terapêutico , Sulbactam/uso terapêutico , Adulto , Intervalos de Confiança , Método Duplo-Cego , Feminino , Humanos , Recém-Nascido , Gravidez , Risco
17.
J Soc Gynecol Investig ; 3(4): 191-8, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8796830

RESUMO

OBJECTIVE: To document and quantify the temporal hemodynamic changes occurring in the pelvic circulation in normal human pregnancy, and to compare these changes with those found 6 weeks postpartum. METHODS: Thirty-three patients had color pulsed Doppler evaluation of the right hypogastric artery six times during pregnancy and once 6 weeks postpartum. Pulsed Doppler waveforms were digitized to assess the time velocity integral (area under the Doppler curve = TVI) and the peak flow velocity (maximum velocity = PFV). The diameter of the vessel was determined during systole using high-resolution two-dimensional ultrasound from a longitudinal plane. A quantitative estimate of the blood flow through this vessel was calculated by multiplying the TVI by the calculated cross-sectional area of the vessel. RESULTS: The cross-sectional area and the indexed volume of blood flow per minute of the hypogastric artery were significantly greater during pregnancy compared with the postpartum value. The estimated vascular resistance index was significantly decreased during pregnancy. Time velocity integral was significantly lower at the initial study compared with the postpartum value. CONCLUSION: The hypogastric artery undergoes significant hemodynamic changes during pregnancy when compared to the postpartum period. Furthermore, the pelvic circulation displays these changes early in gestation.


Assuntos
Artérias/fisiologia , Período Pós-Parto/fisiologia , Gravidez/fisiologia , Estômago/irrigação sanguínea , Adulto , Artérias/diagnóstico por imagem , Velocidade do Fluxo Sanguíneo , Feminino , Idade Gestacional , Frequência Cardíaca , Humanos , Fluxo Sanguíneo Regional , Ultrassonografia Doppler em Cores , Resistência Vascular
18.
Am J Obstet Gynecol ; 174(3): 1043-9, 1996 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8633634

RESUMO

OBJECTIVES: Our purpose was to determine whether estrogen alters the relaxation responses to bradykinin and superoxide dismutase of the uterine and renal arteries and to determine the role of nitric oxide in that response. STUDY DESIGN: Ten nulliparous, ovariectomized nonpregnant sheep received either estradiol-17beta or vehicle solution. In vitro studies evaluating vasorelaxation were done with either bradykinin or superoxide dismutase. The nitric oxide inhibitor nomega-nitro-L-arginine methyl ester was used to determine the role of nitric oxide in this process. Nitric oxide synthase activity was assessed by measuring citrulline generation. RESULTS: We found a dose dependency of relaxation to bradykinin and superoxide dismutase. Estrogen enhanced this response in uterine arteries. Estrogen increased citrulline generation in uterine but not renal arteries. Nomega-nitro-L-arginine methyl ester blocked relaxation responses and citrulline generation in both arteries. CONCLUSION: In nonpregnant sheep we found that nitric oxide release and nitric oxide synthase activity is enhanced by estrogen in the uterine arteries but not in the renal arteries. Increases in nitric oxide synthase activity may be important in the hyperemic response of the uterus during estrus.


Assuntos
Estradiol/farmacologia , Óxido Nítrico/biossíntese , Artéria Renal/efeitos dos fármacos , Útero/irrigação sanguínea , Vasodilatação/efeitos dos fármacos , Análise de Variância , Animais , Arginina/análogos & derivados , Arginina/farmacologia , Artérias/efeitos dos fármacos , Artérias/metabolismo , Artérias/fisiologia , Bradicinina/farmacologia , Citrulina/metabolismo , Inibidores Enzimáticos/farmacologia , Feminino , Técnicas In Vitro , NG-Nitroarginina Metil Éster , Óxido Nítrico/fisiologia , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico Sintase/metabolismo , Artéria Renal/metabolismo , Artéria Renal/fisiologia , Ovinos , Superóxido Dismutase/farmacologia
19.
Int J Gynaecol Obstet ; 52(2): 141-4, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8855092

RESUMO

OBJECTIVE: To evaluate the perinatal morbidity and mortality of fetuses diagnosed with gastroschisis at our Fetal Diagnosis and Treatment Center. METHODS: A retrospective review of a regional prenatal diagnostic center. Twenty-nine cases of gastroschisis which were diagnosed, managed, delivered and had corrective surgeries through the Fetal Diagnosis and Treatment Center were identified from 1985 to 1994. Perinatal morbidity and mortality were reviewed. Antepartum testing schemes were reviewed when available to determine whether morbidity or mortality could have potentially been prevented. RESULTS: Meconium occurrence, intrauterine growth retardation (IUGR) and oligohydramnios complicated 79%, 41% and 36% of the cases, respectively. The perinatal mortality of this series was 241/1000. Significant differences in perinatal mortality were noted when fetal testing was incorporated (200/1000 vs. 286/1000, P < or = 0.001). CONCLUSION: Gastroschisis is associated with a high incidence of IUGR, meconium, oligohydramnios and high perinatal mortality. Antenatal testing appears to significantly lower perinatal mortality in pregnancies complicated by gastroschisis.


Assuntos
Músculos Abdominais/anormalidades , Morte Fetal/epidemiologia , Doenças Fetais/prevenção & controle , Monitorização Fetal , Feminino , Retardo do Crescimento Fetal/epidemiologia , Humanos , Mecônio/metabolismo , Oligo-Hidrâmnio/epidemiologia , Gravidez , Estudos Retrospectivos , alfa-Fetoproteínas/análise
20.
Am J Nephrol ; 16(6): 529-31, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8955766

RESUMO

We report a case of a second trimester multifetal pregnancy with preeclampsia associated with an elevated digoxin-like immune factor. Due to the remoteness from viability the patient was offered therapy with digoxin-binding immunoglobulin. No untoward maternal effects were noted.


Assuntos
Digoxina/sangue , Fragmentos Fab das Imunoglobulinas/uso terapêutico , Pré-Eclâmpsia/sangue , Gravidez Múltipla , Saponinas/sangue , Adulto , Cardenolídeos , Digoxina/imunologia , Feminino , Humanos , Pré-Eclâmpsia/tratamento farmacológico , Gravidez , Segundo Trimestre da Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...